文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

骨盆骨髓保护调强放射治疗减少宫颈癌患者的骨密度丢失

Pelvic Bone Marrow Sparing Intensity Modulated Radiation Therapy Reduces the Bone Mineral Density Loss of Patients With Cervical Cancer.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2024-07-28

该随机对照研究将非手术宫颈癌Ib2-IIIc期患者分为骨盆骨髓保护调强放射治疗(PBMS)组和对照组,PBMS组额外接受骨盆骨髓剂量约束。结果显示,PBMS组末次随访时全部骨骼骨密度较基线下降43%,对照组下降53%,PBMS-IMRT较单纯IMRT减少了骨密度丢失。

要点

  • PBMS组末次随访全部骨骼骨密度较基线下降43%,对照组下降53%。
  • 未接受延伸野放疗者上腰椎受照极少,仍检测到骨密度下降22.33%。
  • PBMS组腰椎或骨盆骨折发生率为7.8%,对照组为12.79%。

核心结论

  • 骨盆放疗后骨密度丢失可在放疗后早期出现,且可发生于照射野内或照射野外。
  • 本研究结果显示,与单纯IMRT相比,PBMS-IMRT减少了骨密度丢失。

研究设计与样本

  • 随机将非手术宫颈癌Ib2-IIIc期患者分配至PBMS组或对照组,PBMS组额外接受骨盆骨髓剂量约束。
  • PBMS组90例、对照组86例纳入统计分析,其中分别有30例和26例接受延伸野放疗(EFR)。
  • 全部患者中位随访12个月,在基线和治疗后1、3、6、9、12个月采集CT影像,配准放射剂量与亨氏单位,记录不同随访时间点的骨密度丢失率和骨折事件。

主要发现

  • 与基线相比,末次随访时PBMS组全部骨骼骨密度下降43%,对照组下降53%,治疗后1个月下降最显著。
  • 未接受EFR的患者上腰椎受照极少,仍检测到骨密度下降22.33%;接受EFR的患者骨密度下降51.18%(P < .01)。
  • PBMS组腰椎或骨盆骨折发生率为7.8%,对照组为12.79%。
  • 在剂量学参数中,平均剂量与骨密度丢失的相关性最强。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To test the efficacy and feasibility of pelvic bone marrow sparing intensity modulated radiation therapy (PBMS-IMRT) in reducing bone density loss for patients with cervical cancer undergoing pelvic radiation therapy (RT). METHODS AND MATERIALS: Patients with nonsurgical cervical cancer with stage Ib2-IIIc cancer were randomly allocated into the PBMS group or the control group. The PBMS group additionally received pelvic bone marrow dose constraint. Computed tomography (CT) imaging sets were acquired at baseline and at 1, 3, 6, 9, and 12 months after treatment. Radiation dose and Hounsfield unit were registered. Bone density loss rates and fracture events at different follow-up time points were recorded. RESULTS: Data from 90 patients in the PBMS group and 86 patients in the control group were used for statistical analysis, which included 30 and 26 patients with extended-field radiation therapy (EFR), respectively. The median follow-up for all patients was 12 months. Compared with baseline, the bone density of all bones at the last follow-up decreased by 43% and 53% in the PBMS and control groups, respectively, with the most significant decline at 1 month after treatment. Although patients without EFR received minimal irradiation in the upper lumbar spine, a 22.33% decrease in bone density was detected. In the group of patients with EFR, the decrease was 51.18% (P < .01). Lumbar or pelvic fracture incidence rates of patients in the PBMS and control groups were 7.8% and 12.79%, respectively. Among the dosimetric parameters, mean dose had the strongest correlation with bone density loss. CONCLUSIONS: In patients undergoing pelvic RT, the loss of bone density can begin to appear early after RT, and it can occur either inside or outside of the irradiation field. Results of this study showed that PBMS-IMRT reduced bone mineral density loss compared with IMRT alone.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Huang J, Gao J, Zhang F, et al. Pelvic Bone Marrow Sparing Intensity Modulated Radiation Therapy Reduces the Bone Mineral Density Loss of Patients With Cervical Cancer. Int J Radiat Oncol Biol Phys. 2024. PMID: 39074565. doi:10.1016/j.ijrobp.2024.07.2314

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。